155 related articles for article (PubMed ID: 21947419)
1. SLC39A2 and FSIP1 polymorphisms as potential modifiers of arsenic-related bladder cancer.
Karagas MR; Andrew AS; Nelson HH; Li Z; Punshon T; Schned A; Marsit CJ; Morris JS; Moore JH; Tyler AL; Gilbert-Diamond D; Guerinot ML; Kelsey KT
Hum Genet; 2012 Mar; 131(3):453-61. PubMed ID: 21947419
[TBL] [Abstract][Full Text] [Related]
2. A case-control study of polymorphisms in xenobiotic and arsenic metabolism genes and arsenic-related bladder cancer in New Hampshire.
Lesseur C; Gilbert-Diamond D; Andrew AS; Ekstrom RM; Li Z; Kelsey KT; Marsit CJ; Karagas MR
Toxicol Lett; 2012 Apr; 210(1):100-6. PubMed ID: 22306368
[TBL] [Abstract][Full Text] [Related]
3. Genetic variation in glutathione S-transferase omega-1, arsenic methyltransferase and methylene-tetrahydrofolate reductase, arsenic exposure and bladder cancer: a case-control study.
Beebe-Dimmer JL; Iyer PT; Nriagu JO; Keele GR; Mehta S; Meliker JR; Lange EM; Schwartz AG; Zuhlke KA; Schottenfeld D; Cooney KA
Environ Health; 2012 Jun; 11():43. PubMed ID: 22747749
[TBL] [Abstract][Full Text] [Related]
4. Positive association between aspirin-intolerant asthma and genetic polymorphisms of FSIP1: a case-case study.
Kim JY; Kim JH; Park TJ; Bae JS; Lee JS; Pasaje CF; Park BL; Cheong HS; Park JS; Park SW; Uh ST; Kim MK; Choi IS; Cho SH; Choi BW; Park CS; Shin HD
BMC Pulm Med; 2010 Jun; 10():34. PubMed ID: 20513247
[TBL] [Abstract][Full Text] [Related]
5. Identification and replication of the interplay of four genetic high-risk variants for urinary bladder cancer.
Selinski S; Blaszkewicz M; Ickstadt K; Gerullis H; Otto T; Roth E; Volkert F; Ovsiannikov D; Moormann O; Banfi G; Nyirady P; Vermeulen SH; Garcia-Closas M; Figueroa JD; Johnson A; Karagas MR; Kogevinas M; Malats N; Schwenn M; Silverman DT; Koutros S; Rothman N; Kiemeney LA; Hengstler JG; Golka K
Carcinogenesis; 2017 Dec; 38(12):1167-1179. PubMed ID: 29028944
[TBL] [Abstract][Full Text] [Related]
6. Comparing the joint effect of arsenic exposure, cigarette smoking and risk genotypes of vascular endothelial growth factor on upper urinary tract urothelial carcinoma and bladder cancer.
Wang YH; Yeh SD; Wu MM; Liu CT; Shen CH; Shen KH; Pu YS; Hsu LI; Chiou HY; Chen CJ
J Hazard Mater; 2013 Nov; 262():1139-46. PubMed ID: 23009795
[TBL] [Abstract][Full Text] [Related]
7. Disinfection By-Products in Drinking Water and Bladder Cancer: Evaluation of Risk Modification by Common Genetic Polymorphisms in Two Case-Control Studies.
Beane Freeman LE; Kogevinas M; Cantor KP; Villanueva CM; Prokunina-Olsson L; Florez-Vargas O; Figueroa JD; Ward MH; Koutros S; Baris D; Garcia-Closas M; Schwenn M; Johnson A; Serra C; Tardon A; Garcia-Closas R; Carrato A; Malats N; Karagas MR; Rothman N; Silverman DT
Environ Health Perspect; 2022 May; 130(5):57006. PubMed ID: 35536285
[TBL] [Abstract][Full Text] [Related]
8. Genetic susceptible locus in NOTCH2 interacts with arsenic in drinking water on risk of type 2 diabetes.
Pan WC; Kile ML; Seow WJ; Lin X; Quamruzzaman Q; Rahman M; Mahiuddin G; Mostofa G; Lu Q; Christiani DC
PLoS One; 2013; 8(8):e70792. PubMed ID: 23967108
[TBL] [Abstract][Full Text] [Related]
9. Potential effect modifiers of the arsenic-bladder cancer risk relationship.
Koutros S; Baris D; Waddell R; Beane Freeman LE; Colt JS; Schwenn M; Johnson A; Ward MH; Hosain GM; Moore LE; Stolzenberg-Solomon R; Rothman N; Karagas MR; Silverman DT
Int J Cancer; 2018 Dec; 143(11):2640-2646. PubMed ID: 29981168
[TBL] [Abstract][Full Text] [Related]
10. Concordance of multiple analytical approaches demonstrates a complex relationship between DNA repair gene SNPs, smoking and bladder cancer susceptibility.
Andrew AS; Nelson HH; Kelsey KT; Moore JH; Meng AC; Casella DP; Tosteson TD; Schned AR; Karagas MR
Carcinogenesis; 2006 May; 27(5):1030-7. PubMed ID: 16311243
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive pathway-based interrogation of genetic variations in the nucleotide excision DNA repair pathway and risk of bladder cancer.
Xing J; Dinney CP; Shete S; Huang M; Hildebrandt MA; Chen Z; Gu J
Cancer; 2012 Jan; 118(1):205-15. PubMed ID: 21692063
[TBL] [Abstract][Full Text] [Related]
12. Micronuclei in exfoliated bladder cells among individuals chronically exposed to arsenic in drinking water.
Moore LE; Smith AH; Hopenhayn-Rich C; Biggs ML; Kalman DA; Smith MT
Cancer Epidemiol Biomarkers Prev; 1997 Jan; 6(1):31-6. PubMed ID: 8993795
[TBL] [Abstract][Full Text] [Related]
13. Decreased DNA repair gene expression among individuals exposed to arsenic in United States drinking water.
Andrew AS; Karagas MR; Hamilton JW
Int J Cancer; 2003 Apr; 104(3):263-8. PubMed ID: 12569548
[TBL] [Abstract][Full Text] [Related]
14. Low-level arsenic exposure is associated with bladder cancer risk and cigarette smoking: a case-control study among men in Tunisia.
Feki-Tounsi M; Olmedo P; Gil F; Khlifi R; Mhiri MN; Rebai A; Hamza-Chaffai A
Environ Sci Pollut Res Int; 2013 Jun; 20(6):3923-31. PubMed ID: 23184132
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of genetic variation in the double-strand break repair pathway and bladder cancer risk.
Figueroa JD; Malats N; Rothman N; Real FX; Silverman D; Kogevinas M; Chanock S; Yeager M; Welch R; Dosemeci M; Tardón A; Serra C; Carrato A; García-Closas R; Castaño-Vinyals G; García-Closas M
Carcinogenesis; 2007 Aug; 28(8):1788-93. PubMed ID: 17557904
[TBL] [Abstract][Full Text] [Related]
16. Interaction between arsenic exposure from drinking water and genetic polymorphisms on cardiovascular disease in Bangladesh: a prospective case-cohort study.
Wu F; Jasmine F; Kibriya MG; Liu M; Cheng X; Parvez F; Islam T; Ahmed A; Rakibuz-Zaman M; Jiang J; Roy S; Paul-Brutus R; Slavkovich V; Islam T; Levy D; VanderWeele TJ; Pierce BL; Graziano JH; Ahsan H; Chen Y
Environ Health Perspect; 2015 May; 123(5):451-7. PubMed ID: 25575156
[TBL] [Abstract][Full Text] [Related]
17. Comparison of arsenic methylation capacity and polymorphisms of arsenic methylation genes between bladder cancer and upper tract urothelial carcinoma.
Huang CY; Lin YC; Shiue HS; Chen WJ; Su CT; Pu YS; Ao PL; Hsueh YM
Toxicol Lett; 2018 Oct; 295():64-73. PubMed ID: 29859237
[TBL] [Abstract][Full Text] [Related]
18. Arsenic exposure predicts bladder cancer survival in a US population.
Kwong RC; Karagas MR; Kelsey KT; Mason RA; Tanyos SA; Schned AR; Marsit CJ; Andrew AS
World J Urol; 2010 Aug; 28(4):487-92. PubMed ID: 19834714
[TBL] [Abstract][Full Text] [Related]
19. Arsenic in private well water may contribute to bladder cancer risk.
Printz C
Cancer; 2016 Aug; 122(15):2291. PubMed ID: 27441754
[No Abstract] [Full Text] [Related]
20. Polymorphisms in GSTT1, GSTZ1, and CYP2E1, disinfection by-products, and risk of bladder cancer in Spain.
Cantor KP; Villanueva CM; Silverman DT; Figueroa JD; Real FX; Garcia-Closas M; Malats N; Chanock S; Yeager M; Tardon A; Garcia-Closas R; Serra C; Carrato A; Castaño-Vinyals G; Samanic C; Rothman N; Kogevinas M
Environ Health Perspect; 2010 Nov; 118(11):1545-50. PubMed ID: 20675267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
